Shandong Buchang Pharmaceuticals Co.Ltd(603858) (securities code: 603858) announced today that the board of directors of the company received a written resignation report submitted by Li Weijun, a director and vice president of the company. Li Weijun applied to resign as a director, vice president and a member of the remuneration and assessment committee of the board of directors for personal reasons, and resigned all his positions in the company’s subsidiaries at the same time. After resigning from the above position, he will not hold any position in the company.
Shandong Buchang Pharmaceuticals Co.Ltd(603858) said that according to the company law of the people’s Republic of China, the articles of association and other relevant provisions, Li Weijun’s resignation report will take effect from the date it is delivered to the board of directors.
